MétaCan
Menu
Back to cohort

PB2681: GAPS IN THE ASSESSMENT AND MONITORING OF CARDIOVASCULAR RISK AND PSYCHOLOGICAL BURDEN IN POLYCYTHEMIA VERA: LANDMARK 2.0: A WORLDWIDE HEALTH SURVEY

2023· article· en· W4386143084 on OpenAlexaff
Claire Harrison, David M. Ross, Laura Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian H. Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquín Martínez‐López, Alicia Rovó, Cheryl Petruk, Catalin Bobirca, Laura Mirams, Abigail McMillan, Gavin Harper, Jean‐Jacques Kiladjian

Bibliographic record

VenueHemaSphere · 2023
Typearticle
Languageen
FieldMedicine
TopicMyeloproliferative Neoplasms: Diagnosis and Treatment
Canadian institutionsHôpital Maisonneuve-RosemontUniversity of British Columbia
Fundersnot available
KeywordsMedicinePolycythemia veraPhlebotomyQuality of life (healthcare)Internal medicine

Abstract

fetched live from OpenAlex

Topic: 35. Quality of life and palliative care Background: Polycythemia vera (PV) patients (pts) have a high risk of thrombosis and cardiovascular (CV) events are the main cause of death. PV Pts also report reduced quality of life (QoL) due to high symptom and psychological burden. Aims: This study examined patterns in CV risk assessment and PV-related psychological burden, comparing results from physician (phys) and pt perspectives. Methods: The LANDMARK 2.0 survey of PV pts and phys was conducted in 11 countries between April 2021–May 2022. Pts aged 18–89 years (yrs), and phys who were managing PV pts within the preceding 12 months (mo) were included. Pts were stratified by current therapy (tx) stage: first-line cytoreductive tx for ≤1yr (PV-C), second-line tx for ≤1yr (PV-I), or any line of tx for >1yr (PV-M). Results: Overall, 133 phys and 274 PV pts (PV-C =86; PV-I =26; PV-M =162) completed the survey. In the PV-C, PV-I, and PV-M groups, median age was 63, 59, and 64 yrs and time since PV diagnosis was 43, 117, and 312 weeks, respectively. Most common PV treatments were hydroxyurea and ruxolitinib. Phlebotomies were received by 53%, 31%, and 29% pts in PV-C, PV-I, and PV-M stages respectively. Basic CV assessment (e.g., BP and chol) was routinely performed by 77%, 62% and 53% of PV-C, PV-I and PV-M treating phys, respectively. Comprehensive CV assessment (e.g., ECG and/or ECO) was performed less frequently (PV-C=60%; PV-I=47%; PV-M=32%). Among phys who never performed basic (n=21) or comprehensive (n=40) CV assessment, reasons cited include lack of necessity (38% & 43%), insufficient time (38% & 15%) and insufficient resources (19% & 35%). 68% and 63% of all phys believe that basic or comprehensive CV assessment could not be used more effectively in pt management. In contrast, 55% of all pts reported receiving routine basic CV assessment. In particular, PV-C pts reported a lower rate than phys (63% vs 77%). Fewer PV-M pts received advice on reducing CV risk (45% in the last 12mo) vs PV-C and PV-I pts (73% & 69%, respectively, in the last 6mo). Fewer PV-M pts had comprehensive CV assessment compared to PV-C and PV-I pts (42% vs 76% or 59%, respectively). On a scale from 1 (no impact) to 5 (significant impact), when asked how PV affects QoL, most pts (58%) reported an impact of 3–5 on emotional well-being and mental health, especially PV-C (66%) and PV-I (80%) pts. 38% of all pts rated the impact of phlebotomy on QoL as 3–5, 41% of whom experienced stress about managing hematocrit. However, a minority of phys reported ever having assessed the emotional burden of phlebotomy (PV-C, 33%; PV-I, 28%; PV-M, 36%). Among respondents who had ever carried out/received a psychosocial burden assessment during routine visits, fewer pts than phys reporting the assessment being performed always/often (Figure 1). Regarding PV-related psychological burden support received, 52% of pts reported being somewhat/very satisfied. More pts vs phys reported a lack of communication on self-help strategies in PV-I (36% vs 12%) or on the rationale for having performed specific tests in PV-I (20% vs 8%) and PV-C (24% vs 9%).Summary/Conclusion: Control CV risk factors in PV pts is recommended, however, there is no standard method for monitoring CV risk, highlighting an unmet need. These findings indicate that CV-risk education and testing are not typically provided throughout the tx process, particularly for pts who are stabilized on long-term maintenance therapy. Additionally, our findings show pts and phys disagree about the perceived importance of PV-related QoL assessments. Pt care may be enhanced with regular assessments throughout tx and increased communication Keywords: Polycythemia vera, Thrombosis, Myeloproliferative disorder, Quality of life

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.015
Threshold uncertainty score0.422

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.364
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueHemaSphereSame topicMyeloproliferative Neoplasms: Diagnosis and TreatmentFrench-language works237,207